Eye & ENT Hospital of Fudan University
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China17 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ear Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, hereditary disease, nervous system disorder, otorhinolaryngologic disease | Recruiting | Not stated | 2026-08-31 | NCT06237790 | |
| Guangke Lenses in Congenital Cataract | Congenital Cataract | Recruiting | Not applicable | 2026-08-21 | NCT07778797 | |
| Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR) | wet macular degeneration | Recruiting | Phase 3 | 2026-08-06 | NCT07317934 | |
| A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. | eye disorder, uveal disorder, uveitis | Recruiting | Phase 2 | 2026-07-24 | NCT07547995 | |
| Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study | Neoplasms by Histologic Type, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, nasal cavity and paranasal sinus carcinoma, neoplasm | Recruiting | Not stated | 2026-06-17 | NCT07652489 | |
| Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma | Neoplasms by Histologic Type, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2026-06-01 | NCT07616141 | |
| Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid | Nasopharyngeal Cancinoma (NPC); Radiation-induced Oral Mucositis | Recruiting | Phase 3 | 2026-05-07 | NCT07311772 | |
| UGX202 Injection in Patients With Advanced Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Not yet recruiting | Early phase 1 | 2025-12-31 | NCT07311863 | |
| Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis With Nasal Polyps | Recruiting | Phase 3 | 2025-11-17 | NCT07132827 | |
| Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Not yet recruiting | Phase 4 | 2025-10-01 | NCT07200336 | |
| A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss | Ear Diseases, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease | Recruiting | Not applicable | 2025-07-25 | NCT06722170 | |
| Toric Intraocular Lens (IOL) Implantation for Management of Cataracts | Toric Intraocular Lens Stability; Visual Quality | Recruiting | Not stated | 2025-06-19 | NCT05797298 | |
| A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss | Deafness, Ear Diseases, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease, presbycusis | Not yet recruiting | Not applicable | 2025-06-10 | NCT07012746 | |
| Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis | Bacterial Infections and Mycoses, Infections, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, bacterial infectious disease, blindness (disorder), corneal disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Early phase 1 | 2024-06-11 | NCT06451172 | |
| Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma | Locally Advanced Hypopharyngeal Carcinoma | Recruiting | Phase 2 | 2024-04-30 | NCT06151743 | |
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-02-13 | NCT06255210 | |
| Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Respiratory System Abnormalities, glottis carcinoma, laryngeal disorder, laryngeal papillomatosis, laryngostenosis, larynx squamous papilloma, otorhinolaryngologic disease, respiratory system disorder | Recruiting | Phase 1 / Phase 2 | 2023-05-06 | NCT05688488 |